CIK 0001501697
- Non-accelerated filer
- Smaller reporting company
X4 Pharmaceuticals, Inc
Sign in to watch- Ticker
- XFOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273181608
- Phone
- +1 857-529-8300
- Business address
- 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Former names
- Arsanis, Inc.
- Open-market buys, last 90 days
- $11,884
- in 1 filing
- Open-market sales, last 90 days
- $33,658
- in 1 filing
Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-20 | Polaris Venture Management Co. V, L.L.C. 10% owner | Conversion · Series D Convertible Preferred Stock | −2,153,746 | 0 | ||
| 2017-11-20 | Polaris Venture Management Co. V, L.L.C. 10% owner | Conversion · Series D Convertible Preferred Stock | −41,976 | 0 | ||
| 2017-11-20 | Polaris Venture Management Co. V, L.L.C. 10% owner | Conversion · Series D Convertible Preferred Stock | −14,752 | 0 | ||
| 2017-11-20 | Polaris Venture Management Co. V, L.L.C. 10% owner | Conversion · Series D Convertible Preferred Stock | −21,537 | 0 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +19,128 | 19,128 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +404 | 19,532 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +247,010 | 266,542 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +5,219 | 271,761 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +322,102 | 593,863 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +6,806 | 600,669 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +111,955 | 712,624 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +2,365 | 714,989 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +202,915 | 917,904 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +4,288 | 922,192 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +431,980 | 1,354,172 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion | +14,789 | 1,368,961 | ||
| 2017-11-20 | Ross Michael Jay Director | Purchase | +483,448 | $10.00 | $4.8M | 1,852,409 |
| 2017-11-20 | Ross Michael Jay Director | Purchase | +16,552 | $10.00 | $166K | 1,868,961 |
| 2017-11-20 | Ross Michael Jay Director | Conversion · Series A-1 Convertible Preferred Stock | −65,287 | 0 | ||
| 2017-11-20 | Ross Michael Jay Director | Conversion · Series A-1 Convertible Preferred Stock | −1,380 | 0 |
Page 23 of 25 · 490 trades